Search:
   

System Status Messages

Time Market Status
13:56:01 ETNASDAQ
BX
Post - Trade
PSX
NASDAQ Options
BX Options
PHLX
NASDAQ Futures
ISE
GEMX
MRX		Systems are operating normally

Regulatory Messages

Time Market Status
13:56:01 ETNASDAQ
BX
PSX
NASDAQ Options
BX Options
NASDAQ Futures
ISE
GEMX
MRX		There are no messages available

IPO Messages

Time Market Status
13:13:15 ETNASDAQ

IPO Notice Update: The initial public offering of company Bicara Therapeutics Inc. (BCAX) has officially opened for trading.

Time: 13:11:08
Price: $26.25
Shares: 823,615

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





13:08:32 ETNASDAQIPO Notice Update: The initial public offering of security, Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:58:37 ETNASDAQIPO Notice Update: The initial public offering of security, Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:48:56 ETNASDAQIPO Notice Update: The initial public offering of security, Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:40:08 ETNASDAQIPO Notice Update: The initial public offering of security, Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:30:38 ETNASDAQIPO Notice Update: The initial public offering of security, Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:29:50 ETNASDAQ

IPO Notice Update: The initial public offering of MBX Biosciences Inc (MBX) has officially opened for trading.

Time:12:29:04
Price: $23.00
Shares:354,282

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





12:23:33 ETNASDAQ

IPO Notice Update: The initial public offering of company Zenas Biopharma, Inc. (ZBIO) has officially opened for trading.

Time: 12:19:41
Price: $18.35
Shares: 472,727

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





12:20:35 ETNASDAQIPO Notice Update: The initial public offering of Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:13:41 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:05:18 ETNASDAQIPO Notice Update: The initial public offering of Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:04:02 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:56:54 ETNASDAQIPO Notice Update: The initial public offering of security, MBX Biosciences Inc - MBX, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:53:32 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:50:54 ETNASDAQIPO Notice Update: The initial public offering of Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:43:40 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:35:18 ETNASDAQIPO Notice Update: The initial public offering of security, MBX Biosciences Inc - MBX remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:35:15 ETNASDAQIPO Notice Update: The initial public offering of Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:33:36 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:24:02 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:21:03 ETNASDAQIPO Notice Update: The initial public offering of Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:13:48 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:04:04 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:00:25 ETNASDAQIPO Notice Update: The initial public offering of Bicara Therapeutics Inc. (BCAX)  remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:56:07 ETNASDAQIPO Notice Update: The initial public offering of security, MBX - MBX Biosciences Inc, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:54:09 ETNASDAQIPO Notice Update: The initial public offering of security, Zenas Biopharma, Inc. (ZBIO) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:45:34 ETNASDAQIPO Notice Update: The initial public offering of Bicara Therapeutics Inc. (BCAX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



08:22:20 ETNASDAQIPO Notice: The initial public offering of Bicara Therapeutics Inc. (BCAX) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.


08:15:44 ETNASDAQIPO Notice: The initial public offering of Zenas Biopharma, Inc. (ZBIO) will be released on Nasdaq today for quotation at 10:35 a.m. ET and will be eligible for trading at approximately 10:45 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.


08:13:38 ETNASDAQRevision to IPO Release time: The initial public offering of MBX Biosciences, Inc. (MBX) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.




Self-Help Messages

Time Market Status
13:56:01 ETNASDAQ
BX
PSX
NASDAQ Options
NASDAQ Futures
BX Options
PHLX
ISE
GEMX
MRX		There are no messages available